Pharvaris N V 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pharvaris N V 's ROA in the fourth quarter of 2025?
Pharvaris N V recorded a cumulative net loss of $-248 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -72.72%.

However, within the Healthcare sector 672 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4666.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	-40.33 %	-54.67 %	-61.36 %	-16.19 %	229.51 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-248	-84	-107	-141	-141
Return On Assets (TTM)	-72.72 %	-20.83 %	-21.36 %	-22.18 %	-21.63 %
PHVS's Total Ranking	# 4666	#	#	#	# 4790
Total Assets (TTM) in million	353	338	338	338	592
Seq. Total Assets Change	4.65 %	0 %	0 %	-42.99 %	-20.5 %
Seq. Net Income Change	-	-	-	-	-

PHVS's 5 Years Annual ROA >> Back to PHVS Management Effectiveness >> Compare PHVS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 295
Sector	# 673
Overall	# 4625

Return On Assets Statistics
High	Average	Low
-21.06 %	-38.98 %	-56.15 %
(Dec 31 2021)		(Dec 31 2025)

News about Pharvaris N v Return on Assets ROA

Pharvaris Unveils 2025 Strategic Priorities Amid Financial Struggles, Highlighting Innovations in Hereditary Angioedema Treatment.

Pharvaris Charts a Course for Strategic Growth Amidst Financial ChallengesOverview of Pharvaris’ Strategic Vision for 2025ZUG, Switzerland – On January 13, 2025, Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company, unveiled its strategic priorities for the coming year. With a focus on addressing the unmet needs of patients suffering from bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema (AAE), Pharvaris aims to leverage its expertise in developing novel, oral bradykinin B2 receptor antagonists.Recent Financial PerformanceDespite its promising pipeline, Pharvaris has faced notable financial difficulties. For the 12 months ending in the fourth quarter of 2022, the company reported a cumulative net loss of $85 million. This resulted in a troubling negative return on assets (ROA) of -45.51%, which stands in stark contrast to 751 other companies in the healthcare sector that achieved higher returns. The company s overall ranking has significantly worsened since the third quarter of 2022, falling to the 5014th position in ROA metrics.

Financial Statements
Pharvaris N V 's Assets	$ 353 million	PHVS's Balance sheet
Pharvaris N V 's Income	$ -197 million	Quarterly PHVS's Income Statement
PHVS's Income by Division		See PHVS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-40.33 %	-32.23 %	386.21 %	-24.89 %	96.64 %
Total Assets in million	353	592	874	180	239
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-199	-145	-109	-80	-51
Annual Return On Assets	-56.22 %	-24.52 %	-12.49 %	-44.74 %	-21.13 %

PHVS's 5 Years Annual ROA >> Back to PHVS Management Effectiveness >> Compare PHVS ROA to its Competitors

More Return On Assets Ratios
PHVS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PHVS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PHVS's Competitors
Subscribers only: Roa for Pharvaris N V 's Suppliers
Subscribers only: Return On Assets for PHVS's Customers

You may also want to know
PHVS's Roi	PHVS's Inventory Turnover Ratio	PHVS's Growth Rates	PHVS's Dividend Comparisons
	PHVS's Profitability Ratios	PHVS's Asset Turnover Ratio	PHVS's Dividend Growth
PHVS's Roe	PHVS's Valuation Ratios	PHVS's Financial Strength Ratios	PHVS's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T12:34:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.